Frequency and clinicopathologic correlates of ErbB1, ErbB2, and ErbB3 immunoreactivity in urothelial tumors of upper urinary tract
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- HER2 protein overexpression and gene amplification in upper urinary tract transitional cell carcinoma: Systematic analysis applying tissue microarray techniqueUrology, 2005
- Combined Effects of p53, p21, and pRb Expression in the Progression of Bladder Transitional Cell CarcinomaJournal of Clinical Oncology, 2004
- p53, p21, pRB, and p16 Expression Predict Clinical Outcome in Cystectomy With Bladder CancerJournal of Clinical Oncology, 2004
- Unusually high incidence of upper urinary tract urothelial carcinoma in TaiwanUrology, 2002
- A clinicopathological study of bladder cancer associated with upper urinary tract cancerBJU International, 2000
- Unusual clinical presentation of upper urothelial carcinoma in TaiwanCancer, 1999
- The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tractCancer, 1996
- Histopathological Features and p53 Nuclear Protein Staining as Predictors of Survival and Tumor Recurrence in Patients with Transitional Cell Carcinoma of Renal PelvisJournal of Urology, 1995
- Significance of epidermal growth factor receptor and c-erbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumour recurrence at the urinary bladderBritish Journal of Cancer, 1995
- Management of High Grade Transitional Cell Cancer of the Upper Urinary TractJournal of Urology, 1981